sulfacytine

Trade name: renoquid

Small moleculeapproved

Approved

Sep 12, 1975

Sulfacytine is a short-acting sulfonamide, which was used for the treatment uncomplicated urinary tract infections, but was discontinued. This drug is a is a competitive inhibitor of the dihydropteroate synthetase, that inhibits bacterial synthesis of dihydrofolic acid by preventing the condensation of the peridine with para-aminobenzoic acid (PABA), a substrate of the enzyme dihydropteroate synthetase. — NCATS

Clinical trial activity

0 trials · 0 clinical orgs · 2 marketing orgs

Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0

Timeline

1970s

  1. Sep 12, 1975

    American Home Products — Earliest FDA Approval

  2. Sep 12, 1975

    Glenwood Pharmaceuticals — NDA Secondary Org

  3. Sep 12, 1975

    American Home Products — NDA Organization

Indications

Mechanism of action

Approval history

  • approvedPriority reviewSep 12, 1975

Chemistry & pharmacology

Loading structure…

SMILES

CCN1C=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NC1=O
Mol. weight
294.33 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Achiral Molecule
Inorganic
No
Polymer
No
Delivery
Oral
Availability
Discontinued

Oral

Yes

Parenteral

No

Topical

No

Sources

Also known as

  • 1-ethyl n4-sulfanilylcytosin
  • 1-ethyl n4-sulfanilylcytosin
  • 1-ethyl-n-sulfanilylcytosine
  • 1-ethyl-n-sulfanilylcytosine
  • ci-636
  • ci-636
  • n(1)-(1-ethyl-1,2-dihydro-2-oxo-4-pyrimidinyl)sulfanilamide
  • n-sulfanilyl-l-ethylcytosine
  • n-sulfanilyl-l-ethylcytosine
  • renoquid
  • renoquid
  • renoquid
  • renoquid
  • renoquid
  • sulfacitina
  • sulfacitina
  • sulfacitine
  • sulfacitine
  • sulfacitine
  • sulfacitine
  • sulfacitinum
  • sulfacitinum
  • sulfacytine
  • sulfacytine
  • sulfacytine
  • sulfacytine
  • sulfacytine
  • sulfacytine
  • sulfacytine
  • sulfacytine
  • sulfacytine
  • sulfacytine

Organizations

Marketing (2)

OrganizationOrg typeRelationshipDate
American Home ProductsFor profitNDASep 12, 1975
Glenwood PharmaceuticalsFor profitNDA2Sep 12, 1975